newsfilter
← Latest News
GlobeNewswire·

Avalon GloboCare Receives Allowance for Joint U.S. Patent

FREEHOLD, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ:AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today provided an update regarding the Company's intellectual property portfolio